Correlation between P53 immunohistochemical staining and TP53 molecular testing in endometrial carcinomas: a detailed assessment of discrepant cases with implications for patient management

Documenti analoghi

• Practical guidance for assessing and reporting lymphovascular space invasion (LVSI) in endometrial carcinoma
  di: Elke E M Peters, et al.
  Pubblicazione: (2024)
• Gynaecological serous carcinomas exhibiting squamous differentiation: exploding a myth
  di: Lucy Hamer, et al.
  Pubblicazione: (2025)
• Folate receptor alpha ( FRα / FOLR1 ) and HER2 immunohistochemical staining in high‐grade endometrial carcinoma with aberrant p53 expression
  di: Austin McHenry, et al.
  Pubblicazione: (2025)
• Editorial: Infiltrative pattern of invasion is independently associated with shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian carcinoma
  di: Carlos Parra‐Herran, et al.
  Pubblicazione: (2024)
• DICER1 ‐associated ‘yolk sac tumour’ or ‘foetal‐type adenocarcinoma?’: questioning historical terminology
  di: Kyle M Devins, et al.
  Pubblicazione: (2026)